Silence Therapeutics (SLN) Current Leases (2023 - 2026)

Silence Therapeutics has reported Current Leases for 8 years, with the latest figure at $93000.0 in Q1 2026.

• Quarterly Current Leases rose 55.0% year-over-year to $93000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $93000.0 (up 55.0% YoY) and the FY2025 annual result came in at $89000.0, down 23.93% from the prior year.
• Current Leases rose to $93000.0 in Q1 2026 per SLN's latest filing, from $89000.0 in the prior quarter.
• Over five years, Current Leases peaked at $523126.0 in Q4 2022 and troughed at $60000.0 in Q1 2025.
• A 5-year average of $169898.9 and a median of $93000.0 in 2026 frame the typical range for Current Leases.
• The sharpest annual moves came in 2022 and 2023: Current Leases soared 183.26% in 2022, then plunged 57.53% in 2023.
• Over 5 years, Current Leases stood at $523126.0 in 2022, then slumped by 57.53% to $222166.2 in 2023, then sank by 47.34% to $117000.0 in 2024, then dropped by 23.93% to $89000.0 in 2025, then climbed by 4.49% to $93000.0 in 2026.
• According to Business Quant data, Current Leases over the past three periods registered $93000.0, $89000.0, and $85000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.